vs

Side-by-side financial comparison of Professional Diversity Network, Inc. (IPDN) and INVO Fertility, Inc. (IVF). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.7M, roughly 1.1× Professional Diversity Network, Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -173.5%, a 23.0% gap on every dollar of revenue. On growth, INVO Fertility, Inc. posted the faster year-over-year revenue change (22.6% vs 3.1%). Professional Diversity Network, Inc. produced more free cash flow last quarter ($1.4M vs $-1.8M). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -1.7%).

Professional Diversity Network, Inc. is a U.S.-based firm offering end-to-end diversity, equity and inclusion (DEI) solutions for corporate clients. Its services include targeted recruitment support for underrepresented talent groups, customized DEI training programs, and diversity performance data analytics, serving clients across tech, healthcare, finance and other core commercial sectors nationwide.

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

IPDN vs IVF — Head-to-Head

Bigger by revenue
IVF
IVF
1.1× larger
IVF
$1.8M
$1.7M
IPDN
Growing faster (revenue YoY)
IVF
IVF
+19.5% gap
IVF
22.6%
3.1%
IPDN
Higher net margin
IVF
IVF
23.0% more per $
IVF
-150.5%
-173.5%
IPDN
More free cash flow
IPDN
IPDN
$3.2M more FCF
IPDN
$1.4M
$-1.8M
IVF
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-1.7%
IPDN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
IPDN
IPDN
IVF
IVF
Revenue
$1.7M
$1.8M
Net Profit
$-2.9M
$-2.6M
Gross Margin
33.7%
Operating Margin
-173.2%
-93.1%
Net Margin
-173.5%
-150.5%
Revenue YoY
3.1%
22.6%
Net Profit YoY
-280.0%
-62.2%
EPS (diluted)
$-0.77

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IPDN
IPDN
IVF
IVF
Q4 25
$1.7M
Q3 25
$1.7M
$1.8M
Q2 25
$1.6M
$1.9M
Q1 25
$1.5M
$1.6M
Q4 24
$1.6M
$1.7M
Q3 24
$1.7M
$1.4M
Q2 24
$1.7M
$1.8M
Q1 24
$1.7M
$1.6M
Net Profit
IPDN
IPDN
IVF
IVF
Q4 25
$-2.9M
Q3 25
$-2.4M
$-2.6M
Q2 25
$-476.0K
$-5.3M
Q1 25
$-722.1K
$-17.4M
Q4 24
$-761.9K
$-3.6M
Q3 24
$-405.0K
$-1.6M
Q2 24
$-553.1K
$-2.2M
Q1 24
$-791.8K
$-1.6M
Gross Margin
IPDN
IPDN
IVF
IVF
Q4 25
33.7%
Q3 25
44.0%
Q2 25
43.4%
Q1 25
52.2%
35.2%
Q4 24
58.6%
41.4%
Q3 24
58.9%
31.0%
Q2 24
62.9%
53.1%
Q1 24
62.2%
45.3%
Operating Margin
IPDN
IPDN
IVF
IVF
Q4 25
-173.2%
Q3 25
-136.3%
-93.1%
Q2 25
-30.2%
-160.4%
Q1 25
-46.9%
-1042.1%
Q4 24
-36.8%
-202.0%
Q3 24
-25.0%
-90.7%
Q2 24
-34.4%
-100.9%
Q1 24
-46.5%
-95.7%
Net Margin
IPDN
IPDN
IVF
IVF
Q4 25
-173.5%
Q3 25
-136.2%
-150.5%
Q2 25
-29.0%
-283.6%
Q1 25
-48.0%
-1060.1%
Q4 24
-47.1%
-211.3%
Q3 24
-23.9%
-113.8%
Q2 24
-32.7%
-122.2%
Q1 24
-45.9%
-101.3%
EPS (diluted)
IPDN
IPDN
IVF
IVF
Q4 25
Q3 25
$-0.77
Q2 25
$-13.30
Q1 25
$-12.53
Q4 24
$14.86
Q3 24
$-15.11
Q2 24
$-22.39
Q1 24
$-7.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IPDN
IPDN
IVF
IVF
Cash + ST InvestmentsLiquidity on hand
$217.0K
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$11.7M
$5.8M
Total Assets
$17.9M
$18.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IPDN
IPDN
IVF
IVF
Q4 25
$217.0K
Q3 25
$265.3K
Q2 25
$125.1K
Q1 25
$496.4K
Q4 24
$1.7M
Q3 24
$133.7K
Q2 24
$619.3K
Q1 24
$97.1K
Total Debt
IPDN
IPDN
IVF
IVF
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IPDN
IPDN
IVF
IVF
Q4 25
$11.7M
Q3 25
$8.9M
$5.8M
Q2 25
$4.5M
$2.6M
Q1 25
$4.9M
$3.3M
Q4 24
$5.3M
$12.7M
Q3 24
$2.1M
$-23.3K
Q2 24
$2.5M
$1.4M
Q1 24
$2.3M
$10.2K
Total Assets
IPDN
IPDN
IVF
IVF
Q4 25
$17.9M
Q3 25
$12.1M
$18.8M
Q2 25
$7.3M
$19.3M
Q1 25
$7.7M
$31.7M
Q4 24
$8.0M
$46.4M
Q3 24
$5.3M
$17.0M
Q2 24
$5.8M
$17.8M
Q1 24
$5.7M
$17.3M
Debt / Equity
IPDN
IPDN
IVF
IVF
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IPDN
IPDN
IVF
IVF
Operating Cash FlowLast quarter
$1.4M
$-1.8M
Free Cash FlowOCF − Capex
$1.4M
$-1.8M
FCF MarginFCF / Revenue
84.4%
-101.6%
Capex IntensityCapex / Revenue
0.0%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IPDN
IPDN
IVF
IVF
Q4 25
$1.4M
Q3 25
$-2.7M
$-1.8M
Q2 25
$-495.5K
$-1.7M
Q1 25
$-284.1K
$-3.5M
Q4 24
$-1.2M
$-617.4K
Q3 24
$-556.9K
$-640.8K
Q2 24
$-224.4K
$-1.5M
Q1 24
$-543.1K
$-260.6K
Free Cash Flow
IPDN
IPDN
IVF
IVF
Q4 25
$1.4M
Q3 25
$-2.7M
$-1.8M
Q2 25
$-499.5K
$-1.7M
Q1 25
$-3.6M
Q4 24
$-1.2M
$-696.3K
Q3 24
$-558.9K
Q2 24
$-225.9K
$-1.5M
Q1 24
$-543.6K
$-310.3K
FCF Margin
IPDN
IPDN
IVF
IVF
Q4 25
84.4%
Q3 25
-156.8%
-101.6%
Q2 25
-30.4%
-92.6%
Q1 25
-216.9%
Q4 24
-74.0%
-40.6%
Q3 24
-33.0%
Q2 24
-13.4%
-82.3%
Q1 24
-31.5%
-19.7%
Capex Intensity
IPDN
IPDN
IVF
IVF
Q4 25
0.0%
Q3 25
0.0%
0.5%
Q2 25
0.2%
0.5%
Q1 25
0.0%
0.9%
Q4 24
1.3%
4.6%
Q3 24
0.1%
0.0%
Q2 24
0.1%
3.0%
Q1 24
0.0%
3.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons